US Stock MarketDetailed Quotes

TRDA Entrada Therapeutics

Watchlist

18.820
+0.770+4.27%

Trading Nov 22 13:10 ET

704.24MMarket Cap13.07P/E (TTM)

Entrada Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

0.92%-24.27M

213.51%39.83M

-112.55%-25.52M

249.07%139.8M

85.30%-4.01M

10.88%-24.49M

-94.85%-35.09M

1,068.98%203.4M

-84.39%-93.79M

-32.92%-27.3M

Net income from continuing operations

-139.57%-14.03M

312.25%55.03M

452.05%23.5M

92.93%-6.69M

61.25%-9.54M

241.07%35.46M

-11.86%-25.93M

69.20%-6.67M

-84.95%-94.62M

-33.51%-24.63M

Depreciation and amortization

12.35%937K

24.66%910K

72.64%934K

49.92%2.84M

39.92%736K

61.63%834K

57.67%730K

38.72%541K

69.65%1.9M

44.51%526K

Change In working capital

79.44%-12.82M

-63.14%-18.47M

-124.95%-51.65M

1,326.85%136.32M

149.39%2.95M

-1,025.92%-62.33M

-652.24%-11.32M

12,676.79%207.01M

-224.79%-11.11M

-55.82%-5.98M

-Change in receivables

495.86%5.07M

2,635.61%69.84M

-1,037.62%-71.64M

---5.88M

---853K

---1.28M

--2.55M

---6.3M

--0

-Change in prepaid assets

91.39%-1.27M

-143.88%-2.87M

-38.23%2.68M

161.49%8.62M

725.17%12.52M

-55.36%-14.78M

881.03%6.55M

359.82%4.34M

-108.26%-14.02M

68.14%-2M

-Change in payables and accrued expense

114.60%865K

51.04%-1.01M

-129.00%-1.35M

-28.63%5.03M

3,240.64%8.39M

-248.21%-5.92M

-191.39%-2.07M

767.48%4.64M

117.09%7.05M

-68.55%251K

-Change in other current assets

43.47%2.61M

59.77%4.59M

148.29%2.56M

-87.14%426K

146.70%1.03M

-6.23%1.82M

11.97%2.87M

-619.71%-5.3M

1,100.91%3.31M

-239.07%-2.21M

-Change in other current liabilities

20.98%-3.13M

70.72%-1.99M

7.79%-1.8M

-59.20%-11.86M

141.76%841K

-101.63%-3.96M

-249.79%-6.79M

-27.37%-1.95M

---7.45M

---2.01M

-Change in other working capital

55.60%-16.97M

-503.22%-87.02M

-91.54%17.9M

--139.98M

---18.97M

---38.21M

---14.43M

--211.58M

----

Cash from discontinued investing activities

Operating cash flow

0.92%-24.27M

213.51%39.83M

-112.55%-25.52M

249.07%139.8M

85.30%-4.01M

10.88%-24.49M

-94.85%-35.09M

1,068.98%203.4M

-84.39%-93.79M

-32.92%-27.3M

Investing cash flow

Cash flow from continuing investing activities

-2,119.08%-82.93M

78.47%-24.38M

164.65%26.15M

6.90%-138.4M

1.34%19.04M

63.12%-3.74M

-567.52%-113.26M

77.72%-40.44M

-3,145.63%-148.65M

1,521.48%18.79M

Net PPE purchase and sale

55.87%-639K

31.27%-1.05M

49.76%-838K

-94.46%-5.61M

-37.85%-976K

-78.77%-1.45M

-96.39%-1.52M

-180.81%-1.67M

36.97%-2.89M

46.44%-708K

Net investment purchase and sale

-3,494.93%-82.29M

79.11%-23.34M

169.59%26.99M

8.91%-132.78M

2.66%20.02M

75.45%-2.29M

-546.94%-111.74M

78.57%-38.78M

---145.76M

--19.5M

Cash from discontinued investing activities

Investing cash flow

-2,119.08%-82.93M

78.47%-24.38M

164.65%26.15M

6.90%-138.4M

1.34%19.04M

63.12%-3.74M

-567.52%-113.26M

77.72%-40.44M

-3,145.63%-148.65M

1,521.48%18.79M

Financing cash flow

Cash flow from continuing financing activities

-102.99%-11K

22,781.94%101.37M

-98.95%206K

4,291.86%21.04M

92.74%690K

513.33%368K

3,927.27%443K

38,972.00%19.54M

-99.84%479K

-99.81%358K

Net common stock issuance

--0

--19.41M

--0

--19.41M

--0

Proceeds from stock option exercised by employees

-102.99%-11K

22,781.94%101.37M

59.69%206K

240.29%1.63M

92.74%690K

513.33%368K

3,927.27%443K

158.00%129K

-48.99%479K

459.38%358K

Cash from discontinued financing activities

Financing cash flow

-102.99%-11K

22,781.94%101.37M

-98.95%206K

4,291.86%21.04M

92.74%690K

513.33%368K

3,927.27%443K

38,972.00%19.54M

-99.84%479K

-99.81%358K

Net cash flow

Beginning cash position

126.07%189.2M

-68.74%72.39M

45.71%71.55M

-83.13%49.11M

-2.50%55.83M

-11.73%83.69M

161.43%231.6M

-83.13%49.11M

645.46%291.06M

-53.13%57.26M

Current changes in cash

-284.78%-107.2M

178.98%116.82M

-99.54%834K

109.28%22.45M

292.79%15.72M

25.81%-27.86M

-2,475.22%-147.91M

190.13%182.49M

-196.01%-241.96M

-104.83%-8.15M

End cash Position

46.87%82M

126.07%189.2M

-68.74%72.39M

45.71%71.55M

-2.50%55.83M

-11.73%83.69M

161.43%231.6M

-83.13%49.11M

Free cash flow

3.99%-24.91M

205.94%38.79M

-113.07%-26.36M

238.81%134.19M

82.19%-4.99M

8.31%-25.94M

-94.92%-36.61M

1,034.59%201.73M

-74.37%-96.67M

-28.13%-28.01M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	0.92%-24.27M	213.51%39.83M	-112.55%-25.52M	249.07%139.8M	85.30%-4.01M	10.88%-24.49M	-94.85%-35.09M	1,068.98%203.4M	-84.39%-93.79M	-32.92%-27.3M
Net income from continuing operations	-139.57%-14.03M	312.25%55.03M	452.05%23.5M	92.93%-6.69M	61.25%-9.54M	241.07%35.46M	-11.86%-25.93M	69.20%-6.67M	-84.95%-94.62M	-33.51%-24.63M
Depreciation and amortization	12.35%937K	24.66%910K	72.64%934K	49.92%2.84M	39.92%736K	61.63%834K	57.67%730K	38.72%541K	69.65%1.9M	44.51%526K
Change In working capital	79.44%-12.82M	-63.14%-18.47M	-124.95%-51.65M	1,326.85%136.32M	149.39%2.95M	-1,025.92%-62.33M	-652.24%-11.32M	12,676.79%207.01M	-224.79%-11.11M	-55.82%-5.98M
-Change in receivables	495.86%5.07M	2,635.61%69.84M	-1,037.62%-71.64M	---5.88M	---853K	---1.28M	--2.55M	---6.3M	--0	--0
-Change in prepaid assets	91.39%-1.27M	-143.88%-2.87M	-38.23%2.68M	161.49%8.62M	725.17%12.52M	-55.36%-14.78M	881.03%6.55M	359.82%4.34M	-108.26%-14.02M	68.14%-2M
-Change in payables and accrued expense	114.60%865K	51.04%-1.01M	-129.00%-1.35M	-28.63%5.03M	3,240.64%8.39M	-248.21%-5.92M	-191.39%-2.07M	767.48%4.64M	117.09%7.05M	-68.55%251K
-Change in other current assets	43.47%2.61M	59.77%4.59M	148.29%2.56M	-87.14%426K	146.70%1.03M	-6.23%1.82M	11.97%2.87M	-619.71%-5.3M	1,100.91%3.31M	-239.07%-2.21M
-Change in other current liabilities	20.98%-3.13M	70.72%-1.99M	7.79%-1.8M	-59.20%-11.86M	141.76%841K	-101.63%-3.96M	-249.79%-6.79M	-27.37%-1.95M	---7.45M	---2.01M
-Change in other working capital	55.60%-16.97M	-503.22%-87.02M	-91.54%17.9M	--139.98M	---18.97M	---38.21M	---14.43M	--211.58M	----	----
Cash from discontinued investing activities
Operating cash flow	0.92%-24.27M	213.51%39.83M	-112.55%-25.52M	249.07%139.8M	85.30%-4.01M	10.88%-24.49M	-94.85%-35.09M	1,068.98%203.4M	-84.39%-93.79M	-32.92%-27.3M
Investing cash flow
Cash flow from continuing investing activities	-2,119.08%-82.93M	78.47%-24.38M	164.65%26.15M	6.90%-138.4M	1.34%19.04M	63.12%-3.74M	-567.52%-113.26M	77.72%-40.44M	-3,145.63%-148.65M	1,521.48%18.79M
Net PPE purchase and sale	55.87%-639K	31.27%-1.05M	49.76%-838K	-94.46%-5.61M	-37.85%-976K	-78.77%-1.45M	-96.39%-1.52M	-180.81%-1.67M	36.97%-2.89M	46.44%-708K
Net investment purchase and sale	-3,494.93%-82.29M	79.11%-23.34M	169.59%26.99M	8.91%-132.78M	2.66%20.02M	75.45%-2.29M	-546.94%-111.74M	78.57%-38.78M	---145.76M	--19.5M
Cash from discontinued investing activities
Investing cash flow	-2,119.08%-82.93M	78.47%-24.38M	164.65%26.15M	6.90%-138.4M	1.34%19.04M	63.12%-3.74M	-567.52%-113.26M	77.72%-40.44M	-3,145.63%-148.65M	1,521.48%18.79M
Financing cash flow
Cash flow from continuing financing activities	-102.99%-11K	22,781.94%101.37M	-98.95%206K	4,291.86%21.04M	92.74%690K	513.33%368K	3,927.27%443K	38,972.00%19.54M	-99.84%479K	-99.81%358K
Net common stock issuance	--0	--0	--0	--19.41M	--0	--0	--0	--19.41M	--0	--0
Proceeds from stock option exercised by employees	-102.99%-11K	22,781.94%101.37M	59.69%206K	240.29%1.63M	92.74%690K	513.33%368K	3,927.27%443K	158.00%129K	-48.99%479K	459.38%358K
Cash from discontinued financing activities
Financing cash flow	-102.99%-11K	22,781.94%101.37M	-98.95%206K	4,291.86%21.04M	92.74%690K	513.33%368K	3,927.27%443K	38,972.00%19.54M	-99.84%479K	-99.81%358K
Net cash flow
Beginning cash position	126.07%189.2M	-68.74%72.39M	45.71%71.55M	-83.13%49.11M	-2.50%55.83M	-11.73%83.69M	161.43%231.6M	-83.13%49.11M	645.46%291.06M	-53.13%57.26M
Current changes in cash	-284.78%-107.2M	178.98%116.82M	-99.54%834K	109.28%22.45M	292.79%15.72M	25.81%-27.86M	-2,475.22%-147.91M	190.13%182.49M	-196.01%-241.96M	-104.83%-8.15M
End cash Position	46.87%82M	126.07%189.2M	-68.74%72.39M	45.71%71.55M	45.71%71.55M	-2.50%55.83M	-11.73%83.69M	161.43%231.6M	-83.13%49.11M	-83.13%49.11M
Free cash flow	3.99%-24.91M	205.94%38.79M	-113.07%-26.36M	238.81%134.19M	82.19%-4.99M	8.31%-25.94M	-94.92%-36.61M	1,034.59%201.73M	-74.37%-96.67M	-28.13%-28.01M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data